Marshall Wace, LLP Inspire Md, Inc. Call Options Transaction History
Marshall Wace, LLP
- $77.3 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding NSPR
# of Institutions
28Shares Held
9.89MCall Options Held
0Put Options Held
0-
Nantahala Capital Management, LLC New Canaan, CT2.21MShares$5.63 Million0.35% of portfolio
-
Orbimed Advisors LLC San Diego, CA2.13MShares$5.44 Million0.13% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT1.38MShares$3.51 Million0.31% of portfolio
-
Velan Capital Investment Management LP Alpharetta, GA904KShares$2.31 Million5.02% of portfolio
-
Pura Vida Investments, LLC New York, NY451KShares$1.15 Million0.83% of portfolio
About InspireMD, Inc.
- Ticker NSPR
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 8,323,200
- Market Cap $21.2M
- Description
- InspireMD, Inc., a medical device company, focuses on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of vascular and coronary diseases in Europe, Latin America, the Middle East, and Asia Pacific. The company offers CGuard carotid embolic prevention system for use in carotid artery applic...